J9062 — Injection, amivantamab 5 mg and hyaluronidase-lpuj
J9062 is a HCPCS Level II code for injection, amivantamab 5 mg and hyaluronidase-lpuj. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J9062
- Long descriptor
- Injection, amivantamab 5 mg and hyaluronidase-lpuj
- Short descriptor
- Inj amivantamab 5mg hyaluron
- Added
- July 1, 2026
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9062
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9062 is not quite right, the correct code is very often within a few positions of it.
- J9054Injection, bortezomib (boruzu), 0.1 mg
- J9055Injection, cetuximab, 10 mg
- J9056Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9057Injection, copanlisib, 1 mg
- J9058Injection, bendamustine hydrochloride (apotex), 1 mgterminated
- J9059Injection, bendamustine hydrochloride (baxter), 1 mgterminated
- J9060Injection, cisplatin, powder or solution, 10 mg
- J9061Injection, amivantamab-vmjw, 2 mg
- J9063Injection, mirvetuximab soravtansine-gynx, 1 mg
- J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065Injection, cladribine, per 1 mg
- J9070Cyclophosphamide, 100 mgterminated
- J9071Injection, cyclophosphamide (auromedics), 5 mg
- J9072Injection, cyclophosphamide (frindovyx), 5 mg
- J9073Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074Injection, cyclophosphamide (sandoz), 5 mg
Questions about J9062
What is HCPCS code J9062?
J9062 is a HCPCS Level II code for injection, amivantamab 5 mg and hyaluronidase-lpuj. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9062?
The CMS HCPCS file marks J9062 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J9062 paid under the physician fee schedule?
J9062 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).